The in vivo experiments also confirmed that SQWF can alleviate COPD by regulating the probiotic Parabacteroides through targeting HDAC1 and RelA to modulate the NET signaling pathway. This evidence concerns the gene HDAC1 and chronic obstructive pulmonary disease.